X4 Pharmaceuticals Inc (XFOR)
NASDAQ:XFOR
Holding XFOR?
Track your performance easily

X4 Pharmaceuticals (XFOR) Financial Statements

816 Followers

X4 Pharmaceuticals Financial Overview

X4 Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.697; its P/E ratio is -1.01; X4 Pharmaceuticals is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is
gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-$ 49.00K$ 49.00K$ 48.00K$ 49.00K
Gross Profit-$ 49.00K$ 49.00K$ 48.00K$ 49.00K
EBIT$ -36.12M$ -17.21M$ -645.00K$ -54.55M$ -29.18M
EBITDA$ -36.06M$ -17.15M--$ 0.00
Net Income Common Stockholders$ -51.77M$ -19.13M$ -2.31M$ -55.71M$ -24.02M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 80.87M$ 114.22M$ 141.68M$ 141.31M$ 93.41M
Total Assets$ 112.18M$ 147.26M$ 173.29M$ 173.40M$ 123.42M
Total Debt$ 58.27M$ 3.71M$ 3.96M$ 5.04M$ 5.11M
Net Debt$ -22.59M$ -110.50M$ -137.72M$ -136.27M$ -88.30M
Total Liabilities$ 111.15M$ 96.16M$ 105.70M$ 105.86M$ 72.73M
Stockholders Equity$ 1.04M$ 51.10M$ 67.59M$ 67.50M$ 51.63M
Cash Flow-
Free Cash Flow$ -33.66M$ -27.77M---
Operating Cash Flow$ -33.60M$ -27.73M$ -20.83M--
Investing Cash Flow$ -5.32M$ -4.83M$ -5.16M--
Financing Cash Flow-$ 97.00K$ 21.20M--
Currency in USD

X4 Pharmaceuticals Earnings and Revenue History

X4 Pharmaceuticals Debt to Assets

X4 Pharmaceuticals Cash Flow

X4 Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis